Advertisement

Human T-Cell Leukemia Viruses, T-Cell Leukemia and Aids

  • R. C. Gallo
  • M. G. Sarngadharan
  • J. Schupbach
  • M. Popovic
  • P. Markham
  • S. Z. Salahuddin
  • S. Arya
  • M. S. ReitzJr.
Chapter
Part of the Experimental Biology and Medicine book series (EBAM, volume 9)

Abstract

HTLV is the name we gave the first retrovirus isolates. Most of these are very closely related, and are called human T-cell leukemia virus type I (HTLV-I). HTLV-I is endemic, but at low rates, in southern Japan, the Caribbean, South and Central America, the southeastern U.S., and especially Africa. Viruses closely related to, but distinct from, HTLV-I have been demonstrated in Old World monkeys. This finding, as well as seroepidemiology, led us to propose that HTLV originated in Africa. HTLV-I has been shown to be the direct cause of an aggressive form of adult T-cell leukemia/lymphoma. The mechanisms which result in in vitro immortalization and in vivo malignancy are not yet known but apparently do not seem to involve visible consistent chromosomal changes, continuous expression of virus, or any of the known onc genes. Whatever the mechanism for growth induction in vitro by HTLV-I, its efficiency in causing malignancy may be because of its dual major effects on infected cells. These are: (1) immortalization of some T cells, especially those which are 0KT4+, and (2) abrogation of function and/or cytopathic changes in others. We have discovered a second class of human T-lymphotropic retroviruses (HTLV-II), in collaboration with D. Golde and colleagues. It shares many of the properties of HTLV-I but has major difference in the genome. It has been isolated only twice, once from a patient with hairy cell leukemia, and recently from a patient with AIDS. HTLV-III is the third member of the HTLV family.

Keywords

Bovine Leukemia Virus Mycosis Fungoides Hairy Cell Leukemia Specific Integration Site Nucleic Acid Homology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D. A. Morgan, F. W. Ruscetti, R. C. Gallo, Science 193, 1007 (1976).PubMedCrossRefGoogle Scholar
  2. 2.
    F. W. Ruscetti, D. A. Morgan, R. C. Gallo, J. Immunol. 119, 131 (1977).PubMedGoogle Scholar
  3. 3.
    B. J. Poiesz et al, Proc. Natl. Acad. Sci. USA 77, 7415 (1980).PubMedCrossRefGoogle Scholar
  4. 4.
    B. J. Poiesz, F. W. Ruscetti, M. S. Reitz, V. S. Kalyanaraman, R. C. Gallo, Nature 294, 268 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    M. S. Reitz, B. J. Poiesz, F. W. Ruscetti, R. C. Gallo, Proc. Natl. Acad. Sci. USA 78, 1887 (1981).PubMedCrossRefGoogle Scholar
  6. 6.
    V. S. Kalyanaraman, M. G. Sarngadharan, B. J. Poiesz, F. W. Ruscetti, R. C. Gallo, J. Virol. 38, 906 (1981).PubMedGoogle Scholar
  7. 7.
    M. Robert-Guroff, F. W. Ruscetti, L. E. Posner, B. J. Poiesz, R. C. Gallo, J. Exp. Med. 154, 1957 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    H. M. Rho, B. J. Poiesz, F. W. Ruscetti, R. C. Gallo, Virology 112, 355 (1981).PubMedCrossRefGoogle Scholar
  9. 9.
    R. C. Gallo et al., Proc. Natl. Acad. Sci. USA 79, 4680 (1982).Google Scholar
  10. 10.
    M. Yoshida, I. Miyoshi, Y. Hinuma, Proc. Natl. Acad. Sci. USA 79, 2031 (1982).PubMedCrossRefGoogle Scholar
  11. 11.
    L. E. Posner et al., J. Exp. Med. 154, 333 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    D. W. Blayney et al., JAMA 250, 1048 (1983).PubMedCrossRefGoogle Scholar
  13. 13.
    D. Catovsky et al, Lancet i, 639, (1982).CrossRefGoogle Scholar
  14. 14.
    K. Takatsuki, J. Uchiyama, K. Sagawa, J. Yodoi, in Topics in Hematology, S. Seno, F. Takaku, S. Irino, Eds. (Excerpta Medica, Amsterdam-Oxford, 1977), pp 73–77.Google Scholar
  15. 15.
    V. S. Kalyanaraman et al., Proc. Natl. Acad. Sci. USA 79, 1653 (1982).PubMedCrossRefGoogle Scholar
  16. 16.
    M. Robert-Guroff et al., Science 215, 975 (1982).PubMedCrossRefGoogle Scholar
  17. 17.
    W. A. Blattner, et al., Int. J. Cancer 30, 257 (1982).PubMedCrossRefGoogle Scholar
  18. 18.
    I. Miyoshi et al., Nature 294, 770 (1981).PubMedCrossRefGoogle Scholar
  19. 19.
    T. Watanabe, M. Seiki, M. Yoshida, Virology 133, 238 (1984).PubMedCrossRefGoogle Scholar
  20. 20.
    R. C. Gallo et al., Cancer Res. 43, 3892 (1983).PubMedGoogle Scholar
  21. 21.
    W. C. Saxinger et al., Science (in press).Google Scholar
  22. 22.
    K. Tajima et al., Gann (in press).Google Scholar
  23. 23.
    T. Miyoshi et al., Gann 71, 155 (1981).Google Scholar
  24. 24.
    M. Popovic et al., Science 219, 856 (1983).PubMedCrossRefGoogle Scholar
  25. 25.
    M. Popovic, G. Lange-Wantzin, P. S. Sarin, D. Mann, R. C. Gallo, Proc. Natl. Acad. Sci. USA 80, 5402 (1983).PubMedCrossRefGoogle Scholar
  26. 26.
    D. L. Mann et al., J. Immunol. 131, 2021 (1983).PubMedGoogle Scholar
  27. 27.
    D. L. Mann et al., Nature 305, 58 (1983).PubMedCrossRefGoogle Scholar
  28. 28.
    H. Mitsuya et al., J. Exp. Med. 158, 994 (1983).PubMedCrossRefGoogle Scholar
  29. 29.
    H. Mitsuya et al., Science 223, 1293 (1984).PubMedCrossRefGoogle Scholar
  30. 30.
    H. Mitsuya et al., Science (in press).Google Scholar
  31. 31.
    M. Popovic et al., Science (in press).Google Scholar
  32. 32.
    P. D. Markham, S. Z. Salahuddin, B. Macchi, M. Robert-Guroff, R. C. Gallo, Int. J. Cancer 33, 13 (1984).PubMedCrossRefGoogle Scholar
  33. 33.
    V. S. Kalyanaraman et al., Science 218, 571 (1982).PubMedCrossRefGoogle Scholar
  34. 34.
    T. H. Lee et al., Proc. Natl. Acad. Sci. USA (in press)Google Scholar
  35. 35.
    V. S. Kalyanaraman, M. Jarvis-Morar, M. G. Sarngadharan, R. C. Gallo, Virology 132, 61 (1984).PubMedCrossRefGoogle Scholar
  36. 36.
    M. S. Reitz, Jr., M. Popovic, B. F. Haynes, S. C. Clark, R. C. Gallo, Virology 126, 688 (1983).PubMedCrossRefGoogle Scholar
  37. 37.
    M. Seiki, S. Hattori, Y. Hirayama, M. Yoshida, Proc. Natl. Acad. Sci. USA 80, 3618 (1983).PubMedCrossRefGoogle Scholar
  38. 38.
    G. M. Shaw et al., Proc. Natl. Acad. Sci. USA 81, 4544 (1984).CrossRefGoogle Scholar
  39. 39.
    W. A. Haseltine et al., Science 225, 419 (1984).PubMedCrossRefGoogle Scholar
  40. 40.
    J. Sodroski et al., Science 225, 421 (1984).PubMedCrossRefGoogle Scholar
  41. 41.
    J. Sodroski et al., Proc. Natl. Acad. Sci. USA (in press).Google Scholar
  42. 42.
    F. Wong-Staal et al., Nature 302, 626 (1983).PubMedCrossRefGoogle Scholar
  43. 43.
    M. Yoshida, M. Seiki, K. Yamaguchi, K. Takatsuki, Proc. Natl. Acad. Sci. USA 81, 2534 (1984).PubMedCrossRefGoogle Scholar
  44. 44.
    J. G. Sodroski, C. A. Rosen, W. A. Haseltine, Science 225, 381 (1984).PubMedCrossRefGoogle Scholar
  45. 45.
    I. S. Y. Chen, J. McLaughlin, D. W. Golde, Nature 309, 276 (1980).CrossRefGoogle Scholar
  46. 46.
    M. Essex et al., Science 220, 859 (1983).PubMedCrossRefGoogle Scholar
  47. 47.
    M. Essex et al., Science 221, 1061 (1983).PubMedCrossRefGoogle Scholar
  48. 48.
    M. Popovic, M. G. Sarngadharan, E. Read, R. C. Gallo, Science 224, 497, (1984).PubMedCrossRefGoogle Scholar
  49. 49.
    R. C. Gallo et al., Science 224, 500 (1984).PubMedCrossRefGoogle Scholar
  50. 50.
    J. Schupbach et al., Science 224, 503 (1984).PubMedCrossRefGoogle Scholar
  51. 51.
    S. K. Arya et al., Science (in press).Google Scholar
  52. 52.
    B. H. Hahn et al., (submitted)Google Scholar
  53. 53.
    M. G. Sarngadharan, M. Popovic, L. Bruch, J. Schupbach, R. C. Gallo, Science 224, 506 (1984).PubMedCrossRefGoogle Scholar
  54. 54.
    B. Safai et al., Lancet (June 30), 1438 (1984).Google Scholar
  55. 55.
    F. Barre-Sinoussi et al., Science 220, 868 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc. 1985

Authors and Affiliations

  • R. C. Gallo
    • 1
  • M. G. Sarngadharan
    • 1
  • J. Schupbach
    • 1
  • M. Popovic
    • 1
  • P. Markham
    • 1
  • S. Z. Salahuddin
    • 1
  • S. Arya
    • 1
  • M. S. ReitzJr.
    • 1
  1. 1.Laboratory of Tumor Cell Biology, Developmental Therapeutics Program, Division of Cancer TreatmentNational Cancer InstituteBethesdaUSA

Personalised recommendations